APA (7th ed.) Citation

B, T., A, T., A, K., A, M., E, S., L, M., . . . S, B. L. (2024). The (1,3)-β-D-glucan use for invasive candidiasis diagnosis in non-neutropenic critically ill patients: A prospective cohort study. La Tunisie medicale, 102(12), 1004. https://doi.org/10.62438/tunismed.v102i12.5254

Chicago Style (17th ed.) Citation

B, Tlili, Trifi A, Kallel A, Mehdi A, Seghir E, Messaoued L, Kallel K, Abdellatif S, and Ben Lakhal S. "The (1,3)-β-D-glucan Use for Invasive Candidiasis Diagnosis in Non-neutropenic Critically Ill Patients: A Prospective Cohort Study." La Tunisie Medicale 102, no. 12 (2024): 1004. https://doi.org/10.62438/tunismed.v102i12.5254.

MLA (9th ed.) Citation

B, Tlili, et al. "The (1,3)-β-D-glucan Use for Invasive Candidiasis Diagnosis in Non-neutropenic Critically Ill Patients: A Prospective Cohort Study." La Tunisie Medicale, vol. 102, no. 12, 2024, p. 1004, https://doi.org/10.62438/tunismed.v102i12.5254.